Merck's New Type of Cancer Drug Shows Promise

Merck's New Type of Cancer Drug Shows Promise
Merck & Co. said Sunday an experimental cancer drug showed promise in an early-stage trial of skin-cancer patients, staking the company's ground in an emerging race to develop medicines that unleash the immune system's power to fight malignancies.

Full News here – Read more on Wall Street Journal

Leave a Reply